In this commentary, Michael Bloch, MD, writes about using time in therapeutic range (TTR) to determine dose, dietary recommendations, and a possible need to change anticoagulants for patients on warfarin.
...
In this commentary, Yehuda Handelsman, MD, deconstructs the common misconception that glucose control is the only important factor for managing diabetes and CVD.
